Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man.

NCT03199430 is registered in ClinicalTrials.gov with Swansea University as lead sponsor.

NCT NCT03199430
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03199430 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Polyphenol Epigallocatechin Gallate Lowers Circulating Catecholamine Concentrations and Alters Lipid Metabolism During Graded Exercise in Man.
Lead sponsor
Swansea University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2015
Completion date
February 29, 2016
Enrollment
8 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

egcg influence on catecholamine metabolism